BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 30763323)

  • 1. The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.
    Czimbalmos C; Csecs I; Toth A; Kiss O; Suhai FI; Sydo N; Dohy Z; Apor A; Merkely B; Vago H
    PLoS One; 2019; 14(2):e0211624. PubMed ID: 30763323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete's heart.
    Luijkx T; Cramer MJ; Buckens CF; Zaidi A; Rienks R; Mosterd A; Prakken NH; Dijkman B; Mali WP; Velthuis BK
    Br J Sports Med; 2015 Nov; 49(21):1404-9. PubMed ID: 23770661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance.
    Petersen SE; Selvanayagam JB; Francis JM; Myerson SG; Wiesmann F; Robson MD; Ostman-Smith I; Casadei B; Watkins H; Neubauer S
    J Cardiovasc Magn Reson; 2005; 7(3):551-8. PubMed ID: 15959967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac magnetic resonance T2 mapping and feature tracking in athlete's heart and HCM.
    Gastl M; Lachmann V; Christidi A; Janzarik N; Veulemans V; Haberkorn S; Holzbach L; Jacoby C; Schnackenburg B; Berrisch-Rahmel S; Zeus T; Kelm M; Bönner F
    Eur Radiol; 2021 May; 31(5):2768-2777. PubMed ID: 33063183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of various "classic" echocardiographic and laboratory indices in distinguishing the "gray zone" between athlete's heart and hypertrophic cardiomyopathy: a pilot study.
    Pagourelias ED; Efthimiadis GK; Kouidi E; Zorou P; Giannoglou G; Deligiannis A; Athyros VG; Karagiannis A; Geleris P
    Echocardiography; 2013 Feb; 30(2):131-9. PubMed ID: 23167844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of athlete's heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae.
    Vilades D; Garcia-Moll X; Gomez-Llorente M; Pujadas S; Ferrero-Gregori A; Doñate T; Mirabet S; Leta R; Pons-Lladó G; Carreras F; Cinca J
    Int J Cardiol; 2021 May; 330():232-237. PubMed ID: 33621621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating the athlete's heart from hypertrophic cardiomyopathy.
    Wasfy MM; Weiner RB
    Curr Opin Cardiol; 2015 Sep; 30(5):500-5. PubMed ID: 26196658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Doppler Diastolic Parameters in Differentiating Physiological Left Ventricular Hypertrophy from Hypertrophic Cardiomyopathy.
    Finocchiaro G; Dhutia H; D'Silva A; Malhotra A; Sheikh N; Narain R; Ensam B; Papatheodorou S; Tome M; Sharma R; Papadakis M; Sharma S
    J Am Soc Echocardiogr; 2018 May; 31(5):606-613.e1. PubMed ID: 29482976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Athlete's heart or hypertrophic cardiomyopathy?
    Lauschke J; Maisch B
    Clin Res Cardiol; 2009 Feb; 98(2):80-8. PubMed ID: 18853091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Echocardiographic tissue Doppler imaging analysis of the systolic and early diastolic velocities of the mitral annulus motion in hypertrophic cardiomyopathy and in top-level athletes].
    Butz T; van Buuren F; Mellwig KP; Langer C; Oldenburg O; Treusch KA; Meissner A; Plehn G; Trappe HJ; Horstkotte D; Faber L
    Ultraschall Med; 2012 Oct; 33(5):455-62. PubMed ID: 21294072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multi-modality cardiac imaging approach to the Athlete's heart: an expert consensus of the European Association of Cardiovascular Imaging.
    Galderisi M; Cardim N; D'Andrea A; Bruder O; Cosyns B; Davin L; Donal E; Edvardsen T; Freitas A; Habib G; Kitsiou A; Plein S; Petersen SE; Popescu BA; Schroeder S; Burgstahler C; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):353. PubMed ID: 25681828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy.
    Sharma S; Maron BJ; Whyte G; Firoozi S; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2002 Oct; 40(8):1431-6. PubMed ID: 12392833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy.
    Kübler J; Burgstahler C; Brendel JM; Gassenmaier S; Hagen F; Klingel K; Olthof SC; Blume K; Wolfarth B; Mueller KAL; Greulich S; Krumm P
    Int J Cardiovasc Imaging; 2021 Aug; 37(8):2501-2515. PubMed ID: 34019206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes.
    Pelliccia A; Maron BJ; Culasso F; Spataro A; Caselli G
    JAMA; 1996 Jul; 276(3):211-5. PubMed ID: 8667565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy.
    Pelliccia A; Maron MS; Maron BJ
    Prog Cardiovasc Dis; 2012; 54(5):387-96. PubMed ID: 22386289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac magnetic resonance based deformation imaging: role of feature tracking in athletes with suspected arrhythmogenic right ventricular cardiomyopathy.
    Czimbalmos C; Csecs I; Dohy Z; Toth A; Suhai FI; Müssigbrodt A; Kiss O; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):529-538. PubMed ID: 30382474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes.
    Maron BJ; Pelliccia A; Spataro A; Granata M
    Br Heart J; 1993 Feb; 69(2):125-8. PubMed ID: 8435237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Profile of Athletes With Hypertrophic Cardiomyopathy.
    Sheikh N; Papadakis M; Schnell F; Panoulas V; Malhotra A; Wilson M; Carré F; Sharma S
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003454. PubMed ID: 26198026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
    Chelliah RK; Senior R
    Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.